12:00 AM
 | 
Jan 09, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Apricus Biosciences, Stellar Pharmaceuticals sales and marketing update

Apricus granted Stellar exclusive rights to commercialize MycoVa in Canada to treat onychomycosis. Apricus will...

Read the full 63 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >